N. Khanna , Y. Rathod , J. Manjali , B. Parambil , G. Chinnaswamy , M. Prasad , R. Gollamudi , V. Patil , A. Baheti , K. Gala , S. Shah , P. Panjwani , M. Ramadwar , N. Shetye , S. Qureshi , S. Laskar
{"title":"单侧视网膜母细胞瘤:儿童治疗方案的疗效审计","authors":"N. Khanna , Y. Rathod , J. Manjali , B. Parambil , G. Chinnaswamy , M. Prasad , R. Gollamudi , V. Patil , A. Baheti , K. Gala , S. Shah , P. Panjwani , M. Ramadwar , N. Shetye , S. Qureshi , S. Laskar","doi":"10.1016/j.ijrobp.2024.11.035","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To evaluate treatment outcome of children diagnosed with unilateral retinoblastoma.</div></div><div><h3>Methods</h3><div>Retrospective study of children diagnosed with unilateral retinoblastoma registered at our institute from January 2013 to December 2018 and completed the curative treatment protocol.</div></div><div><h3>Results</h3><div>For the 98 cases analyzed the median age was 24 months. At the time of presentation, 72 had intraocular and 26 had orbital. On imaging extra-scleral spread was observed in 16 patients whereas 18 patients had optic nerve (ON) involvement, 11 patients had both extra-scleral invasion and ON involvement. Majority we ICRB group E (71), and group D=21, group C= 2, group B=4. Majority were IRSS Stage 1(stage0=14, stage1=52, stage2=10, stage3a=21 and stage3b=1). High-risk features on surgical specimen histopathology were ON margin positivity in 6, ON involvement in 21, extra-scleral spread in 3, choroidal invasion in 38 and iris involvement in 10 patients.</div><div>Eneucleation was offered to 78 (Primary=52, secondary=26). Chemotherapy was offered to 68 (chemoreduction=17, adjuvant chemotherapy=51). Intra-arterial chemotherapy was offered to 27 patients as a primary treatment or in conjugation with focal therapy (n=11). Definitive radiotherapy was offered to only 2 patients and 22 patients received adjuvant radiotherapy.</div><div>At a median follow-up of 62 months, 2 patients had local relapse, which was salvaged by focal therapy in one and enucleation in the other. Ten patients who had leptomeningeal relapse had died. The 5-year local control (LC) is 97.6%, event-free survival (EFS) is 88% and overall survival (OS) is 89.5%. Globe was salvaged in only 16 cases. On univariate analysis, orbital disease, extra-scleral spread, ON involvement (imaging), and ON margin positivity, higher ICRB Group and IRSS stage had poor impact on OS.</div></div><div><h3>Conclusion</h3><div>Retinoblastoma is curable with optimal globe salvage rates if detected early. Orbital disease, high risk features on surgical specimen histopathology and leptomeningeal relapse are associated with inferior outcomes.</div></div>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"121 3","pages":"Page e9"},"PeriodicalIF":6.5000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Unilateral Retinoblastoma: Audit of Outcomes of Children treated with Curative Treatment Protocol\",\"authors\":\"N. Khanna , Y. Rathod , J. Manjali , B. Parambil , G. Chinnaswamy , M. Prasad , R. Gollamudi , V. Patil , A. Baheti , K. Gala , S. Shah , P. Panjwani , M. Ramadwar , N. Shetye , S. Qureshi , S. Laskar\",\"doi\":\"10.1016/j.ijrobp.2024.11.035\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>To evaluate treatment outcome of children diagnosed with unilateral retinoblastoma.</div></div><div><h3>Methods</h3><div>Retrospective study of children diagnosed with unilateral retinoblastoma registered at our institute from January 2013 to December 2018 and completed the curative treatment protocol.</div></div><div><h3>Results</h3><div>For the 98 cases analyzed the median age was 24 months. At the time of presentation, 72 had intraocular and 26 had orbital. On imaging extra-scleral spread was observed in 16 patients whereas 18 patients had optic nerve (ON) involvement, 11 patients had both extra-scleral invasion and ON involvement. Majority we ICRB group E (71), and group D=21, group C= 2, group B=4. Majority were IRSS Stage 1(stage0=14, stage1=52, stage2=10, stage3a=21 and stage3b=1). High-risk features on surgical specimen histopathology were ON margin positivity in 6, ON involvement in 21, extra-scleral spread in 3, choroidal invasion in 38 and iris involvement in 10 patients.</div><div>Eneucleation was offered to 78 (Primary=52, secondary=26). Chemotherapy was offered to 68 (chemoreduction=17, adjuvant chemotherapy=51). Intra-arterial chemotherapy was offered to 27 patients as a primary treatment or in conjugation with focal therapy (n=11). Definitive radiotherapy was offered to only 2 patients and 22 patients received adjuvant radiotherapy.</div><div>At a median follow-up of 62 months, 2 patients had local relapse, which was salvaged by focal therapy in one and enucleation in the other. Ten patients who had leptomeningeal relapse had died. The 5-year local control (LC) is 97.6%, event-free survival (EFS) is 88% and overall survival (OS) is 89.5%. Globe was salvaged in only 16 cases. On univariate analysis, orbital disease, extra-scleral spread, ON involvement (imaging), and ON margin positivity, higher ICRB Group and IRSS stage had poor impact on OS.</div></div><div><h3>Conclusion</h3><div>Retinoblastoma is curable with optimal globe salvage rates if detected early. Orbital disease, high risk features on surgical specimen histopathology and leptomeningeal relapse are associated with inferior outcomes.</div></div>\",\"PeriodicalId\":14215,\"journal\":{\"name\":\"International Journal of Radiation Oncology Biology Physics\",\"volume\":\"121 3\",\"pages\":\"Page e9\"},\"PeriodicalIF\":6.5000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Radiation Oncology Biology Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0360301624036095\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0360301624036095","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Unilateral Retinoblastoma: Audit of Outcomes of Children treated with Curative Treatment Protocol
Objectives
To evaluate treatment outcome of children diagnosed with unilateral retinoblastoma.
Methods
Retrospective study of children diagnosed with unilateral retinoblastoma registered at our institute from January 2013 to December 2018 and completed the curative treatment protocol.
Results
For the 98 cases analyzed the median age was 24 months. At the time of presentation, 72 had intraocular and 26 had orbital. On imaging extra-scleral spread was observed in 16 patients whereas 18 patients had optic nerve (ON) involvement, 11 patients had both extra-scleral invasion and ON involvement. Majority we ICRB group E (71), and group D=21, group C= 2, group B=4. Majority were IRSS Stage 1(stage0=14, stage1=52, stage2=10, stage3a=21 and stage3b=1). High-risk features on surgical specimen histopathology were ON margin positivity in 6, ON involvement in 21, extra-scleral spread in 3, choroidal invasion in 38 and iris involvement in 10 patients.
Eneucleation was offered to 78 (Primary=52, secondary=26). Chemotherapy was offered to 68 (chemoreduction=17, adjuvant chemotherapy=51). Intra-arterial chemotherapy was offered to 27 patients as a primary treatment or in conjugation with focal therapy (n=11). Definitive radiotherapy was offered to only 2 patients and 22 patients received adjuvant radiotherapy.
At a median follow-up of 62 months, 2 patients had local relapse, which was salvaged by focal therapy in one and enucleation in the other. Ten patients who had leptomeningeal relapse had died. The 5-year local control (LC) is 97.6%, event-free survival (EFS) is 88% and overall survival (OS) is 89.5%. Globe was salvaged in only 16 cases. On univariate analysis, orbital disease, extra-scleral spread, ON involvement (imaging), and ON margin positivity, higher ICRB Group and IRSS stage had poor impact on OS.
Conclusion
Retinoblastoma is curable with optimal globe salvage rates if detected early. Orbital disease, high risk features on surgical specimen histopathology and leptomeningeal relapse are associated with inferior outcomes.
期刊介绍:
International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.